Pharma Mar, S.A. (OTCMKTS:PHMMF) Short Interest Down 78.0% in May

Pharma Mar, S.A. (OTCMKTS:PHMMF - Get Free Report) was the target of a significant decline in short interest in May. As of May 31st, there was short interest totalling 8,700 shares, a decline of 78.0% from the May 15th total of 39,600 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 100 shares, the days-to-cover ratio is currently 87.0 days.

Pharma Mar Price Performance

OTCMKTS:PHMMF remained flat at $104.49 during trading hours on Thursday. 2,500 shares of the company's stock traded hands, compared to its average volume of 1,266. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.55 and a quick ratio of 2.01. Pharma Mar has a twelve month low of $34.26 and a twelve month high of $105.60. The firm has a 50-day moving average of $90.04 and a 200 day moving average of $89.10.

About Pharma Mar

Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.